Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAptitude Regulatory News (APTD)

Share Price Information for Aptitude (APTD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 355.00
Bid: 357.00
Ask: 368.00
Change: 0.00 (0.00%)
Spread: 11.00 (3.081%)
Open: 372.00
High: 0.00
Low: 0.00
Prev. Close: 355.00
APTD Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update and Notice of Results

6 Jul 2017 07:00

RNS Number : 2365K
Microgen PLC
06 July 2017
 

6 July 2017

 

MICROGEN plc ('Microgen' or 'Group')

 

TRADING UPDATE AND NOTICE OF RESULTS

 

 

Ahead of announcing Interim Results for the six months ended 30 June 2017 on 24 July 2017, Microgen (MCGN.L), a leading provider of business critical software and services, today issues the following update on trading for the financial year to date.

The Group has made excellent progress in the first half of 2017 resulting in a financial performance ahead of the Board's original expectations for the period whilst maintaining margins consistent with the prior year. The Group's two businesses are successfully executing their declared strategy with Aptitude Software delivering strong organic growth and Microgen Financial Systems successfully continuing on its transition towards a business focused on the Trust & Fund Administration ('T&FA') market.

A key highlight for the Group is the continued new business wins that have driven growth in Aptitude Software's recurring revenue base. Since 30 June 2016, the recurring revenue in Aptitude Software has increased 42% to £15.0 million as at 30 June 2017 (H1, 2016: £10.6 million and 31 December 2016: £12.6 million). There has also been exceptional growth in demand for Aptitude Software's implementation services in the first half of the year as a number of clients progress towards going live with the Aptitude Revenue Recognition Engine ('ARRE'). Upon completion of the half year the Board has reviewed the on-going demand for Aptitude Software's implementation services and, whilst clients' requirements continue to evolve, the Board is now confident that the exceptional level of demand experienced in the first six months of the year will continue throughout 2017, leading to a financial performance for the Group significantly ahead of the Board's expectations for the year. 

Opportunities for Aptitude's existing software and its new products provide the business with confidence for future years. Partners are becoming an increasingly important channel for new business, and as they provide a growing proportion of resources for new implementations, and as a number of the larger ARRE projects are completed, the exceptional level of demand for services experienced in 2017 is expected to moderate in 2018.

Microgen Financial Systems has maintained its focus on the T&FA market within the wealth management sector. The acquisition of Primacy Corporation in February 2017, a competitor in the T&FA market, represented the fifth acquisition since December 2014 and further strengthens the position of the business in this market. As a result of this focus T&FA revenues now represent approximately 60% of Microgen Financial Systems' H1 2017 revenue (H1, 2016: 51%), compared to 33% at the beginning of this transition in 2014.

 

Contacts

Ivan Martin, Chairman 020-7496-8100

Philip Wood, Chief Financial Officer

 

James Melville-Ross / Darius Alexander 020-3727-1000

FTI Consulting

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUGUUGMUPMGAA
Date   Source Headline
2nd Apr 201310:58 amRNSTotal Voting Rights
25th Mar 20134:06 pmRNSBlocklisting Interim Review
21st Mar 20134:53 pmRNSAnnual Information Update
21st Mar 20133:33 pmRNSDirectors Shareholdings
21st Mar 20133:28 pmRNSPDMR Shareholding
8th Mar 20132:37 pmRNSPosting of Annual Report and Notice of AGM
25th Feb 20137:00 amRNSPreliminary Results
19th Feb 20137:00 amRNSNotice of Results
4th Jan 201310:03 amRNSBlocklisting Interim Review
30th Nov 20129:24 amRNSTotal Voting Rights
12th Nov 20127:00 amRNSInterim Management Statement
31st Oct 20123:01 pmRNSTotal Voting Rights
23rd Oct 20122:12 pmRNSHolding(s) in Company
28th Sep 20122:15 pmRNSBlocklisting Interim Review
31st Aug 201210:00 amRNSTotal Voting Rights
31st Jul 20129:51 amRNSTotal Voting Rights
26th Jul 20127:00 amRNSTransaction in Own Shares
25th Jul 20127:00 amRNSTransaction in Own Shares
23rd Jul 20127:00 amRNSInterim Results
13th Jul 201210:32 amRNSNotice of Results
4th Jul 201211:12 amRNSBlocklisting Interim Review
2nd Jul 201211:29 amRNSTotal Voting Rights
30th Apr 20129:44 amRNSTotal Voting Rights
24th Apr 20123:51 pmRNSDirectorate Change
24th Apr 201211:14 amRNSResult of AGM
24th Apr 20127:00 amRNSInterim Management Statement
2nd Apr 201212:03 pmRNSBlocklisting Interim Review
30th Mar 20121:23 pmRNSTotal Voting Rights
26th Mar 20123:14 pmRNSDirector/PDMR Shareholding
20th Mar 20121:11 pmRNSAnnual Information Update
12th Mar 20126:21 pmRNSHolding(s) in Company
12th Mar 201212:03 pmRNSPDMR Announcement
6th Mar 20124:37 pmRNSPosting of Annual Report and Notice of AGM
27th Feb 20127:00 amRNSPreliminary Results
14th Feb 201211:16 amRNSNotice of Results
2nd Feb 201210:18 amRNSAppointment of Non-Executive Director
26th Jan 20122:23 pmRNSHolding(s) in Company
16th Jan 20121:11 pmRNSBlocklisting Interim Review
8th Dec 201112:29 pmRNSDirector Declaration
30th Nov 20111:48 pmRNSTotal Voting Rights
9th Nov 20113:33 pmRNSDirector/PDMR Shareholding
1st Nov 20117:00 amRNSInterim Management Statement and Special Dividend
31st Oct 20111:39 pmRNSHolding(s) in Company
31st Oct 20111:34 pmRNSTotal Voting Rights
12th Oct 20113:35 pmRNSApplication for Block Listing
12th Oct 20111:12 pmRNSDirector Declaration
7th Oct 20112:10 pmRNSDirector Declaration
5th Oct 201111:39 amRNSApplication for Block Listing
30th Sep 20114:13 pmRNSTotal Voting Rights
27th Sep 20115:27 pmRNSBlock Listing Return

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.